If you can’t actually make a commercial deal with a product that’s tested and proven like Path-Away during a pandemic then maybe they need to give someone else the rights to sell it. It’s actually crazy! That’s why I saw potential in these other distribution deals, as they could do the effective leg work.
who knows. My thoughts anyway.
If you can’t actually make a commercial deal with a product...
-
- There are more pages in this discussion • 234 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.101K | 220.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1737805 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 414325 | 2 |
View Market Depth
| Last trade - 15.53pm 28/06/2024 (20 minute delay) ? |
| HCT (ASX) Chart |